Search Results - Meaghan Wall

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7 by Meaghan Wall, Kathleen C. Rayeroux, Ruth N. MacKinnon, Adrian Zordan, Lynda J. Campbell

    Published in Haematologica (2012-12-01)
    Get full text
    Article


  2. 2

    A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia by Anna Kalff, Tiffany Khong, Meaghan Wall, Malgorzata Gorniak, Sridurga Mithraprabhu, Lynda J. Campbell, Andrew Spencer

    Published in Haematologica (2015-02-01)
    Get full text
    Article


  3. 3

    Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide by Ing S. Tiong, William S. Stevenson, Meaghan Wall, Yan Zhuang Yap, John F. Seymour, Melita Kenealy, Piers Blombery, the Australasian Leukaemia & Lymphoma Group

    Published in eJHaem (2023-11-01)
    Get full text
    Article


  4. 4

    The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease by Sofie Singbrant, Meaghan Wall, Jennifer Moody, Göran Karlsson, Alistair M. Chalk, Brian Liddicoat, Megan R. Russell, Carl R. Walkley, Stefan Karlsson

    Published in Haematologica (2014-04-01)
    Get full text
    Article


  5. 5

    Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months by Thomas E. Lew, Mary Ann Anderson, Victor S. Lin, Sasanka M. Handunnetti, Neil A. Came, Piers Blombery, David A. Westerman, Meaghan Wall, Constantine S. Tam, Andrew W. Roberts, John F. Seymour

    Published in Blood Advances (2020-01-01)
    Get full text
    Article


  6. 6

    Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia by Melita Kenealy, Mark Hertzberg, Warwick Benson, Kerry Taylor, Ilona Cunningham, Will Stevenson, Devendra Hiwase, Richard Eek, Daniela Zantomio, Steve Jong, Meaghan Wall, Piers Blombery, Tracey Gerber, Marlyse Debrincat, Diana Zannino, John F. Seymour

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  7. 7

    Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2. by Wei Shi, Amanda L Bain, Bjoern Schwer, Fares Al-Ejeh, Corey Smith, Lee Wong, Hua Chai, Mariska S Miranda, Uda Ho, Makoto Kawaguchi, Yutaka Miura, John W Finnie, Meaghan Wall, Jörg Heierhorst, Carol Wicking, Kevin J Spring, Frederick W Alt, Kum Kum Khanna

    Published in PLoS Genetics (2013-01-01)
    Get full text
    Article


  8. 8

    Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol by John Christodoulou, Christopher Gyngell, Stephanie Best, Clara Gaff, Zornitza Stark, Ilias Goranitis, Marc Clausen, Yvonne Bombard, Lilian Downie, Sebastian Lunke, David J Amor, Alison Yeung, Simon Sadedin, Fiona Lynch, Sophie E Bouffler, Danya F Vears, Jade Caruana, Alison Archibald, Paul De Fazio, Ronda F Greaves, Sebastian Hollizeck, Anaita Kanga-Parabia, Nitzan Lang, Riccarda Peters, Erin Tutty, Stefanie Eggers, Crystle Lee, Meaghan Wall

    Published in BMJ Open (2024-04-01)
    Get full text
    Article


  9. 9

    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? by Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

    Published in Blood Cancer Journal (2024-03-01)
    Get full text
    Article


  10. 10

    Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study by Alexander C. Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, Anna Puiggros, Karla Plevova, Anne-Marie van der Kevie-Kersemaekers, Hidde Posthuma, Ana E. Rodriguez-Vicente, Anh Nhi Tran, Gisela Barbany, Larry Mansouri, Rebeqa Gunnarsson, Helen Parker, Eva van den Berg, Mar Bellido, Zadie Davis, Meaghan Wall, Ilaria Scarpelli, Anders Österborg, Lotta Hansson, Marie Jarosova, Paolo Ghia, Pino Poddighe, Blanca Espinet, Sarka Pospisilova, Constantine Tam, Loïc Ysebaert, Florence Nguyen-Khac, David Oscier, Claudia Haferlach, Jacqueline Schoumans, Marian Stevens-Kroef, Eric Eldering, Kostas Stamatopoulos, Richard Rosenquist, Jonathan C. Strefford, Clemens Mellink, Arnon P. Kater

    Published in Haematologica (2020-01-01)
    Get full text
    Article


Search Tools: